Call for Application 2022 Opening soon!
Next Roadshow November 17th
Program Duration 9 months
Ablatus is the creator of Luna, a minimally invasive, uterus-preserving, and inclusive treatment for fibroids. These tumours, which grows in the womb affect up to 80% of women by the age of 50 - with up to half of them affected with debilitating symptoms like period for up to 21 days, impacting quality of life, fertility, and productivity.
Luna is powered by our patented enhanced ablation platform that can be used to destroy cancerous and non-cancerous soft tissues.
Treatment is delivered via a steerable probe through the cervix to tackle hard-to-reach fibroids for up to 80% of women currently not eligible for state-of-the-art technologies without removing the uterus but wishing to avoid invasive surgery.
Babyndex, created by a gynecologist and his economist son, features an FDA-approved microscope paired with a mobile app to analyze saliva crystals for fertility tracking. The app identifies the most fertile days, helping women to effectively track their fertility. Available for iOS and Android, Babyndex is proven to aid users trying to conceive, offering a user-friendly design and reliable results.
Calico Biosystems is addressing the critical unmet need of the poor efficacy of cancer therapeutics for female patients with cancers. Cancer is a leading cause of death which kills one in six women. A main cause is the artificial models currently used for testing anti-cancer drug efficacy; they fail to recapitulate patient tumor complexity. Consequently, most anti-cancer drugs fail to reach approval due to a lack of efficacy and are extremely costly to develop. Further, approved anti-cancer drugs benefit only 10% of cancer patients. Calico Biosystems is the first platform testing drugs directly on female patient tumors thus predicting reliably at the pre-clinical stage the efficacy of drugs in patients.
Calico Biosystems drug testing platform is a game changer in precision oncology with aims at delivering female cancer patients with more potent and affordable drugs.
CareNX is an Indian healthtech start-up which develops & commercializes AI based technologies for women and child health. CareNX's product suit is being used by 1000+ hospitals, 3000+ doctors, 4+ state governments and 6 other countries in SE Asia and Africa and has collectively screened more than 500,000 pregnancies. The impactful work of CareNX has been felicitated by Hon’ble PM Shri. Modi, HM The Queen of England, PM of Great Britain, Commonwealth Secretariat, WHO Director and many more.
CC Diagnostics is an in vitro diagnostic device manufacturer, developing a novel qPCR test for cervical cancer screening. Our Methica test evaluates the levels of methylation of a panel of proprietary tumor-suppressor genes. With this test we can detect up to 97% of all cervical cancer cases, saving thousands of lives and healthcare cost. Our test is compatible with self-collected samples, enabling full cervical screening from home. The assay is best positioned for automation and high-throughput laboratory settings.
Cosm Medical is personalizing gynecological devices for precision care. By leveraging AI, Digital Gynecology software, and 3D printing, Coms has developed Gynethotics™ Pessaries tailored for individual needs. With positive clinical study outcomes and clearance from FDA and Health Canada, these devices address the quality of life and access issues associated with pelvic floor disorders which affect millions of women. Beyond pessaries, Cosm is pioneering a new product category in gynecology to improve the continuum of pelvic care from obstetrics to elderly care ushering in an age of Digital Gynecology.
DeepLook Medical is enhancing Medical Imaging with revolutionary technology. We are creating a future where data-driven imaging enables accurate, efficient, and personalized care across the entire treatment pathway. Flagship product, FDA-cleared DL Precise™ is utilized by Radiologists to automate lesion segmentation, measurement, and visualization with unprecedented precision - all with a single click, especially in dense tissue.
EndoCure provides robotic AI-powered high-resolution ultrasound imaging for superior endometriosis diagnosis and management. Endometriosis, an ailment associated with chronic debilitating pain and infertility impacting 10% of reproductive-age women (equivalent to 200 million globally), poses a significant challenge due to the lack of precise diagnostic tools, resulting in an up to 11-year diagnosis delay. Our solution represents a transformative leap forward not only in the initial diagnosis but also in routine follow-up and surgical planning. It stands alone as the premiere solution offering a comprehensive lesion map to facilitate personalized treatment.
Galena Innovations is developing the Hannah Cervical Cup, the solution to spontaneous preterm birth. Our mission is to change the trajectory of obstetrics from stagnation to innovation by creating solutions that meet the needs of mothers everywhere, from Mississippi to Malawi, ending the health and social inequities that are pervasive in our world, beginning with birth.
Harmonia is a highly specialized women's health platform that combines cutting edge functional medicine treatment with science-backed resolution for underdiagnosed, undertreated and otherwise dismissed female-specific diseases. Initially focused on hyperemesis gravidarum and severe nausea and vomiting during pregnancy, Harmonia's physician-lead research, prognostic, and treatment programs result in superior health outcomes and subsequently enhanced wellbeing and quality of life.
HeroSupport focuses on developing patient-specific devices, particularly immobilization devices using additive manufacturing techniques. We provide comprehensive solutions for radiation-oncology professionals, enabling them to deliver precise and personalized treatments while enhancing patient comfort and reducing treatment times. Our first product, Venus Shell, is designed for breast cancer.
Hormona is reinventing hormone health for women through AI and at home testing. We are the first end-to-end solution for hormone health offering a revolutionary way of testing, monitoring and treatment of hormone issues while completely removing the need for a lab. With Hormona women receive lab grade results in 15 minutes from home alongside actionable tips and guides on how to stabilise and optimise their hormone health. By combining a range of tools from telehealth appointments to symptom reduction plans and medication, Hormona is the first solution addressing hormone related issues while pioneering the area of "Hormone Health”.
Mamotest is an AI powered solution transforming care delivery by democratizing access to cancer screening & diagnosis while providing an efficient path to treatment, specialized in breast cancer management.
Namida is a biotechnology startup specializing in developing and commercializing early cancer detection proteomics tests. Namida’s first product is Auria, the first at-home biological breast cancer screening test powered by tears. Auria will improve the health outcomes for women through convenient early breast cancer detection and presents the opportunity to disrupt the breast cancer screening market that is clinically confusing and has lacked innovation.
Sin Reglas is a one-stop shop for women in menopause that complements DEI efforts and integrates diagnostics, health education, support community for the adoption of healthy habits, health care and marketplace. We have the passion and the commitment to transform the experience of menopause for ALL women so that we can lead healthy and purposeful lives.
Vital Start Health is a University of Pennsylvania startup with a vision of revolutionizing the $500b women’s mental health opportunity starting with a reproductive and maternity mental health platform using Virtual Reality for clinically guided care across pre-conception, birthing and postpartum. Our platform empowers moms and mental health practitioners to prevent and treat Perinatal Mood and Anxiety Disorders more effectively, equitably, and faster using Virtual and Augmented Reality Framework that measures and personalizes care at every stage of the wellness journey on-site at a clinic, health system or workplace and continuing at home virtually.
OvulaRing is the most sophisticated menstrual cycle tracker. It collects 288 temperature data points/day and uses AI for real-time fertile day detection. Useable for non-hormonal contraception, as well as conception and for menstrual cycle-based training. Success rates are higher than with IVF.
CareNX is an Indian healthtech start-up which develops & commercializes AI based technologies for women and child health. CareNX's product suit is being used by 1000+ hospitals, 3000+ doctors, 4+ state governments and 6 other countries in SE Asia and Africa and has collectively screened more than 500,000 pregnancies. The impactful work of CareNX has been felicitated by Hon’ble PM Shri. Modi, HM The Queen of England, PM of Great Britain, Commonwealth Secretariat, WHO Director and many more.
Galena Innovations is developing the Hannah Cervical Cup, the solution to spontaneous preterm birth. Our mission is to change the trajectory of obstetrics from stagnation to innovation by creating solutions that meet the needs of mothers everywhere, from Mississippi to Malawi, ending the health and social inequities that are pervasive in our world, beginning with birth.
Harmonia is a highly specialized women's health platform that combines cutting edge functional medicine treatment with science-backed resolution for underdiagnosed, undertreated and otherwise dismissed female-specific diseases. Initially focused on hyperemesis gravidarum and severe nausea and vomiting during pregnancy, Harmonia's physician-lead research, prognostic, and treatment programs result in superior health outcomes and subsequently enhanced wellbeing and quality of life.
Cosm Medical is personalizing gynecological devices for precision care. By leveraging AI, Digital Gynecology software, and 3D printing, Coms has developed Gynethotics™ Pessaries tailored for individual needs. With positive clinical study outcomes and clearance from FDA and Health Canada, these devices address the quality of life and access issues associated with pelvic floor disorders which affect millions of women. Beyond pessaries, Cosm is pioneering a new product category in gynecology to improve the continuum of pelvic care from obstetrics to elderly care ushering in an age of Digital Gynecology.
Hormona is reinventing hormone health for women through AI and at home testing. We are the first end-to-end solution for hormone health offering a revolutionary way of testing, monitoring and treatment of hormone issues while completely removing the need for a lab. With Hormona women receive lab grade results in 15 minutes from home alongside actionable tips and guides on how to stabilise and optimise their hormone health. By combining a range of tools from telehealth appointments to symptom reduction plans and medication, Hormona is the first solution addressing hormone related issues while pioneering the area of "Hormone Health”.
Vital Start Health is a University of Pennsylvania startup with a vision of revolutionizing the $500b women’s mental health opportunity starting with a reproductive and maternity mental health platform using Virtual Reality for clinically guided care across pre-conception, birthing and postpartum. Our platform empowers moms and mental health practitioners to prevent and treat Perinatal Mood and Anxiety Disorders more effectively, equitably, and faster using Virtual and Augmented Reality Framework that measures and personalizes care at every stage of the wellness journey on-site at a clinic, health system or workplace and continuing at home virtually.
Babyndex, created by a gynecologist and his economist son, features an FDA-approved microscope paired with a mobile app to analyze saliva crystals for fertility tracking. The app identifies the most fertile days, helping women to effectively track their fertility. Available for iOS and Android, Babyndex is proven to aid users trying to conceive, offering a user-friendly design and reliable results.
OvulaRing is the most sophisticated menstrual cycle tracker. It collects 288 temperature data points/day and uses AI for real-time fertile day detection. Useable for non-hormonal contraception, as well as conception and for menstrual cycle-based training. Success rates are higher than with IVF.
Sin Reglas is a one-stop shop for women in menopause that complements DEI efforts and integrates diagnostics, health education, support community for the adoption of healthy habits, health care and marketplace. We have the passion and the commitment to transform the experience of menopause for ALL women so that we can lead healthy and purposeful lives.
Calico Biosystems is addressing the critical unmet need of the poor efficacy of cancer therapeutics for female patients with cancers. Cancer is a leading cause of death which kills one in six women. A main cause is the artificial models currently used for testing anti-cancer drug efficacy; they fail to recapitulate patient tumor complexity. Consequently, most anti-cancer drugs fail to reach approval due to a lack of efficacy and are extremely costly to develop. Further, approved anti-cancer drugs benefit only 10% of cancer patients. Calico Biosystems is the first platform testing drugs directly on female patient tumors thus predicting reliably at the pre-clinical stage the efficacy of drugs in patients.
Calico Biosystems drug testing platform is a game changer in precision oncology with aims at delivering female cancer patients with more potent and affordable drugs.
Ablatus is the creator of Luna, a minimally invasive, uterus-preserving, and inclusive treatment for fibroids. These tumours, which grows in the womb affect up to 80% of women by the age of 50 - with up to half of them affected with debilitating symptoms like period for up to 21 days, impacting quality of life, fertility, and productivity.
Luna is powered by our patented enhanced ablation platform that can be used to destroy cancerous and non-cancerous soft tissues.
Treatment is delivered via a steerable probe through the cervix to tackle hard-to-reach fibroids for up to 80% of women currently not eligible for state-of-the-art technologies without removing the uterus but wishing to avoid invasive surgery.
CC Diagnostics is an in vitro diagnostic device manufacturer, developing a novel qPCR test for cervical cancer screening. Our Methica test evaluates the levels of methylation of a panel of proprietary tumor-suppressor genes. With this test we can detect up to 97% of all cervical cancer cases, saving thousands of lives and healthcare cost. Our test is compatible with self-collected samples, enabling full cervical screening from home. The assay is best positioned for automation and high-throughput laboratory settings.
DeepLook Medical is enhancing Medical Imaging with revolutionary technology. We are creating a future where data-driven imaging enables accurate, efficient, and personalized care across the entire treatment pathway. Flagship product, FDA-cleared DL Precise™ is utilized by Radiologists to automate lesion segmentation, measurement, and visualization with unprecedented precision - all with a single click, especially in dense tissue.
EndoCure provides robotic AI-powered high-resolution ultrasound imaging for superior endometriosis diagnosis and management. Endometriosis, an ailment associated with chronic debilitating pain and infertility impacting 10% of reproductive-age women (equivalent to 200 million globally), poses a significant challenge due to the lack of precise diagnostic tools, resulting in an up to 11-year diagnosis delay. Our solution represents a transformative leap forward not only in the initial diagnosis but also in routine follow-up and surgical planning. It stands alone as the premiere solution offering a comprehensive lesion map to facilitate personalized treatment.
HeroSupport focuses on developing patient-specific devices, particularly immobilization devices using additive manufacturing techniques. We provide comprehensive solutions for radiation-oncology professionals, enabling them to deliver precise and personalized treatments while enhancing patient comfort and reducing treatment times. Our first product, Venus Shell, is designed for breast cancer.
Mamotest is an AI powered solution transforming care delivery by democratizing access to cancer screening & diagnosis while providing an efficient path to treatment, specialized in breast cancer management.
Namida is a biotechnology startup specializing in developing and commercializing early cancer detection proteomics tests. Namida’s first product is Auria, the first at-home biological breast cancer screening test powered by tears. Auria will improve the health outcomes for women through convenient early breast cancer detection and presents the opportunity to disrupt the breast cancer screening market that is clinically confusing and has lacked innovation.